Invivyd (IVVD) Revenue (2024 - 2026)
Invivyd's (IVVD) quarterly Revenue came in at $14.3 million in Q2 2026, up 21.2% on a YoY basis from $11.8 million in Q2 2025, and down 16.98% quarter-over-quarter from $17.2 million in Q4 2025.
Analysis
Invivyd (IVVD) Revenue (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Revenue for 3 consecutive years, with $14.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Revenue rose 21.2% year-over-year to $14.3 million; the trailing twelve-month figure through Jun 2026 stood at $56.4 million (up 22.07% YoY), and the FY2025 full-year result was $53.4 million, up 110.47% from the prior year.
- Revenue declined to $14.3 million in Q2 2026 per IVVD's latest filing, from $17.2 million in the prior quarter.
- Across five years, Revenue topped out at $17.2 million in Q4 2025 and bottomed at $2.3 million in Q2 2024.
- Historically, Revenue has averaged $11.6 million across 3 years, with a median of $12.5 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Revenue jumped 420.58% in 2025, then climbed 21.2% in 2026.
- Over 3 years, Revenue stood at $13.8 million in 2024, then gained by 24.51% to $17.2 million in 2025, then dropped by 16.98% to $14.3 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $14.3 million, $17.2 million, and $13.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | 14.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.29 Mn |
| Dec 31, 2025 | 17.21 Mn |
| Sep 30, 2025 | 13.13 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 11.30 Mn |
| Dec 31, 2024 | 13.82 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 2.26 Mn |